Literature DB >> 15368046

[Testosterone substitution in aging males. Which questions are answered?].

W Krause1.   

Abstract

Testosterone effects different organs. Thus, a substitution of testosterone in the case of hormone deficiency seems plausible. By analysing 61 randomized studies, we demonstrated that in men older than 65 years there is an increase in bone mass (but not a decrease in fracture risk), an increase in lean body mass, and an increase in erythropoiesis. Changes in cardiovascular parameters, serum lipids, muscle mass, sexual functions, cognition and mood, however, are not clearly proven. The prostate is not negatively influenced. The lack of clear hazards from testosterone substitution in the aging male does not indicate unrestricted treatment safety. Until all doubts are cleared, each treatment should be carefully documented and monitored.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368046     DOI: 10.1007/s00120-004-0648-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

Review 1.  Androgens and the ageing male.

Authors:  Anders Juul; Niels E Skakkebaek
Journal:  Hum Reprod Update       Date:  2002 Sep-Oct       Impact factor: 15.610

Review 2.  Diagnosis of partial androgen deficiency in the aging male.

Authors:  A Vermeulen
Journal:  Ann Endocrinol (Paris)       Date:  2003-04       Impact factor: 2.478

Review 3.  Risks of testosterone-replacement therapy and recommendations for monitoring.

Authors:  Ernani Luis Rhoden; Abraham Morgentaler
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

4.  Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.

Authors:  S N Seidman; E Spatz; C Rizzo; S P Roose
Journal:  J Clin Psychiatry       Date:  2001-06       Impact factor: 4.384

Review 5.  Endocrinological aspects of aging in men: is hormone replacement of benefit?

Authors:  H Janssens; D M Vanderschueren
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2000-09       Impact factor: 2.435

Review 6.  Andropause: an old concept in new clothing.

Authors:  John E Morley; H Mitchell Perry
Journal:  Clin Geriatr Med       Date:  2003-08       Impact factor: 3.076

7.  Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction.

Authors:  Antonio Aversa; Andrea M Isidori; Giovanni Spera; Andrea Lenzi; Andrea Fabbri
Journal:  Clin Endocrinol (Oxf)       Date:  2003-05       Impact factor: 3.478

8.  Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study.

Authors:  P Szulc; B Claustrat; F Marchand; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

Review 9.  The effect of androgen supplementation therapy on the prostate.

Authors:  J M Kaufman
Journal:  Aging Male       Date:  2003-09       Impact factor: 5.892

10.  Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial.

Authors:  Harrison G Pope; Geoffrey H Cohane; Gen Kanayama; Arthur J Siegel; James I Hudson
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.